Figure 1
Figure 2
Prognostic variables associated with a 5-year DFS
| Variables | 5-year DFS (%) | P | 95% CI |
|---|---|---|---|
| Histology | 0.79 | 0.35–2.33 | |
| Squamous cell carcinoma | 92.7 | ||
| Adenocarcinoma | 98.2 | ||
| Adenosquamous carcinoma | 83.4 | ||
| Depth of stromal invasion | 0.04 | 1.02–9.00 | |
| 10 millimeters or less | 95.2 | ||
| More than 10 millimeters | 91.1 | ||
| Stromal invasion (%) | 0.27 | 0.60–5.66 | |
| <50% | 94.9 | ||
| >50% | 93.6 | ||
| Tumor size | 0.12 | 0.75–7.97 | |
| 2 centimeters or less | 94.1 | ||
| More than 2 centimeters | 96.6 | ||
| Lymphovascular space invasion | 0.003 | 1.59–32.32 | |
| Negative | 97.4 | ||
| Positive | 90 | ||
| Adjuvant therapy | 0.23 | 0.44–3.87 | |
| No | 94.6 | ||
| Yes | 99.8 |
Outcomes of patients without adjuvant treatment
| Low-risk patients (n = 79) | Intermediate-risk patients (n = 96) | P P < 0.05 was considered as statistically significant. | |
|---|---|---|---|
| Recurrent disease | 3 (3.8%) | 13 (13.5%) | 0.005 |
| Vaginal cuff | 2 (2.5%) | 5 (5.2%) | |
| Pelvis | 1 (1.2%) | 4 (4.2%) | |
| Distant | 0 (0%) | 1 (1%) | |
| Local and distant | 0 (0%) | 3 (3.1%) | |
| Cancer-related deaths | 1 (1.2%) | 8 (8.3%) | 0.03 |